How did this first-of-its-kind platform trial tackle ALS's debilitating disease progression and what can other rare disease study teams learn from it?
Firma's Dr. D.J. Tang shares in a Clinical Researcher article insights on effective data analysis for nontraditional study designs.
More and more global clinical trials are using a hybrid approach to study visits. Find out the biggest challenges--and how to solve them.
What sites and study teams really want to know about using remote, in-home visits as part of their clinical trial protocols. The answers to the most common questions.
Nikki Skirvin was interviewed by Jenni Spinner about multi-national studies in an article for Outsourcing Pharma earlier this year.
In a recent study, researchers looked at two randomized comparative trials evaluating COVID-19 treatments and outlined the problematic gaps created by the use of the Kaplan-Meier method and hazard ratio.
Firma’s Dr. D.J. Tang shares in an Outsourcing-Pharma article why RWD can be useful in drug research and development.
Firma Clinical recently commenced a Scientific Advisory Board for its clinical services, including biometrics/data.
In Outsourcing-Pharma, Melissa Nezos, explains how the pandemic increased the need to bring the study to the patient.
Firma’s Melissa Nezos shares in an Applied Clinical Trials article the important role of home visits in hybrid and decentralized/virtual clinical trials.
Firma Clinical has joined DTRA, an alliance of life sciences and healthcare organizations seeking to accelerate the broad adoption of patient-focused, decentralized clinical trials and research.
Join advocates, life sciences companies, patients, researchers, investors and regulators at the Rare Disease Innovation & Partnering Summit to tackle challenges in furthering therapeutic and curative progress and ensuring patient access.
What does it mean for clinical trials to be truly patient centric? Firma's Melissa Nezos explains in this Outsourcing-Pharma article.
Melissa Nezos’ 5 Minutes, 5 Questions interview explains why Firma's Home Trial Services are part of the “new normal” for clinical trials.
What makes Firma data services different can be distilled into three characteristics: ownership, quality, and knowledge. Here’s how these broad approaches manifest themselves in every engagement we enter.
Bringing together a global gathering of 1,500 leaders in orphan drugs from 50 countries, World Orphan Drug Congress USA will feature over 260 presentations covering all aspects of orphan drug development and rare disease research.
Firma was contracted to lead the clinical trial recruitment effort and collect and process blood samples from participants in their homes.
Firma’s Home Trial Services are seeing more sponsors using home health visits to enhance the clinical trial experience.
Jennifer Goff, RN, Case Manager & Home Infusion Supervisor, tells her story and discusses the impact that home visits have on her patients.
Melissa Nezos joins Firma Clinical as Vice President of Clinical Operations. She brings to Firma 20+ years of clinical operations and project management experience.
Home health solutions can enhance the successful completion of a clinical trial. Learn more from Firma's CEO Michael Woods in this Applied Clinical Trials article.